Tel Aviv University scientists have made progress in developing a treatment using the NAP peptide to counter Alzheimer’s and other neurological conditions (see here previously). Their new compound dramatically decreased the excessive buildup of the protein tau, which misfolds in Alzheimer’s patients.
https://www.biologicalpsychiatryjournal.com/article/S0006-3223(21)01630-9/fulltext